Pending — not yet graded
“Recommends 'Subscribe: Long Term' for Tempsens Instruments IPO. While the IPO valuation appears fully priced at the upper band (P/E of 35.4x on FY26 earnings), the company's strong revenue growth, diversified product portfolio, and expanding international presence justify a valuation premium and make it attractive for long-term investors.”
Tempsens InstrumentsBullishCalled 21 Aug 2026
This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.
Read the original articleSee Anand Rathi Analysis’s full track record